Pulished Date October, 2018
ID: 7104
Share on
Share on

Asia Pacific Orthobiologics Market By Product (Viscosupplementation, Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP And BMAC), By Application (Osteoarthritis And Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries And Maxillofacial & Dental Applications), By End Users (Hospitals, Orthopaedic Clinics, Ambulatory Care Centres, Research And Academic Institutes And Dental Clinics & Facilities) And By Region (Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 7104
Pages: 145

Asia Pacific Orthobiologics Market was worth USD 1.13 billion in 2018 and estimated to be growing at a CAGR of 6.23%, to reach USD 1.53 billion by 2023. Orthobiologics are substances which orthopaedic surgeons use to assist injuries heal more quickly. They are used to make the process of healing of broken bones and injured muscles, tendons, and ligaments better. These products are made from substances which are naturally found in the body. When they are used in higher concentrations, they can help speed up the healing process.

When a muscle, bone or tendon is injured, there is bleeding into the injured area. This bleeding is the base for the healing response. It provides a route for healing factors to reach the injury site. In addition to bleeding, there are three factors which are necessary for healing. All of them are orthobiologic materials. First one is called the matrix, which can be thought of as the house in which the cells live and where they will thrive and eventually make tendon, bone or ligament. Second one is growth factors, which are the many different kinds of proteins which are necessary for cells to work during the healing process. Third is the stem cells, which are special cells in your body which can turn into other types of cells.

The key driving factors of Asia Pacific Orthobiologics market are growing orthopaedic disease and musculoskeletal disease burden Asia Pacific. Moreover, emerging technological innovations in biomaterials which are used in the production of orthobiologics are expected to accelerate the market demand during the forecast period. These predominantly include advent of recombinant biologic agents, modifications in graft designs, cultured tissue scaffolds and stem cell therapy. These advancements are accompanied with the benefits such as reduced surgical time, enhanced biocompatibility and smaller incisions. Furthermore, these novel solutions are presumed to efficiently reduce the recurrence of post-operative complications, which is expected to boost the orthobiologics market during the forecast period.

The Asia Pacific Orthobiologics market is segmented based on product into Viscosupplementation, Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP and BMAC. By application, the market is divided into Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries and Maxillofacial & Dental Applications. By end users, the market is divided into Hospitals, Orthopaedic Clinics, Ambulatory Care Centres, Research and Academic Institutes and Dental Clinics & Facilities.

The Asia Pacific Orthobiologics market is divided based on geography into India, China, Japan, Australia and other parts of the region. Asia Pacific has the third largest market for orthobiologics in the world by share. It is also the fastest growing region in the world. Factors such as growing incidence of musculoskeletal and orthopaedic diseases and rising government support are expected to drive the market growth in the region.

Some of the major players in the market are Medtronic, DePuy Synthes, Zimmer Biomet, Bioventus, Stryker, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences among others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Viscosupplementation       

                                5.1.2 Products  

                                5.1.3 Demineralized Bone Matrices         

                                5.1.4 Synthetic Orthobiologics   

                                5.1.5 Bone Morphogenic Protein             

                                5.1.6 Allografts 

                                5.1.7 Plasma-Rich Protein            

                                5.1.8 Bone Marrow Aspirate Concentrate            

                                5.1.9  Y-o-Y Growth Analysis, By Product              

                                5.1.10  Market Attractiveness Analysis, By Product          

                                5.1.11  Market Share Analysis, By Product            

                5.2 Application                 

                                5.2.1 Osteoarthritis and Degenerative Arthritis  

                                5.2.2 Spinal Fusion          

                                5.2.3 Fracture Recovery               

                                5.2.4 Soft Tissue Injuries              

                                5.2.5 Maxillofacial & Dental Applications               

                                5.2.6 Y-o-Y Growth Analysis, By Application         

                                5.2.7 Market Attractiveness Analysis, By Application       

                                5.2.8 Market Share Analysis, By Application        

                5.3 End Users                    

                                5.3.1 Hospitals  

                                5.3.2 Orthopaedic Clinics              

                                5.3.3 Ambulatory Care Centres 

                                5.3.4 Research and Academic Institutes                

                                5.3.5 Dental Clinics & Facilities   

                                5.3.6 Y-o-Y Growth Analysis, By End Users           

                                5.3.7  Market Attractiveness Analysis, By End Users        

                                5.3.8  Market Share Analysis, By End Users          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Product

                                                6.1.3.2 By Application

                                                6.1.3.3 By End Users

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Product

                                                6.1.4.2 By Application

                                                6.1.4.3 By End Users

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Product

                                                6.1.5.2 By Application

                                                6.1.5.3 By End Users

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Medtronic                   

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 DePuy Synthes                         

                8.3 Zimmer Biomet                         

                8.4 Bioventus                    

                8.5 Stryker                         

                8.6 Harvest Technologies                             

                8.7 Globus                          

                8.8 Orthofix International                            

                8.9 RTI Surgical                 

                8.10 K2M Group                              

                8.11 Kuros Biosciences                  

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and  forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Orthobiologics  Market By Product , From 2018–2023( USD Billion )
  2. Asia Pacific Viscosupplementation Market By Region, From 2018–2023( USD Billion )
  3. Asia Pacific Products Market By Region, From 2018–2023( USD Billion )
  4. Asia Pacific DBM Market By Region, From 2018–2023( USD Billion )
  5. Asia Pacific Synthetic Orthobiologics Market By Region, From 2018–2023( USD Billion )
  6. Asia Pacific BMP Market By Region, From 2018–2023( USD Billion )
  7. Asia Pacific Allografts Market By Region, From 2018–2023( USD Billion )
  8. Asia Pacific PRP  Market By Region, From 2018–2023( USD Billion )
  9. Asia Pacific BMAC Market By Region, From 2018–2023( USD Billion )
  10. Asia Pacific Orthobiologics  Market By Application , From 2018–2023( USD Billion )
  11. Asia Pacific Osteoarthritis and Degenerative Arthritis Market By Region, From 2018–2023( USD Billion )
  12. Asia Pacific Spinal Fusion Market By Region, From 2018–2023( USD Billion )
  13. Asia Pacific Fracture Recovery Market By Region, From 2018–2023( USD Billion )
  14. Asia Pacific Soft Tissue Injuries  Market By Region, From 2018–2023( USD Billion )
  15. Asia Pacific Maxillofacial & Dental Applications Market By Region, From 2018–2023( USD Billion )
  16. Asia Pacific Orthobiologics  Market By End Users , From 2018–2023( USD Billion )
  17. Asia Pacific Hospitals Market By Region, From 2018–2023( USD Billion )
  18. Asia Pacific Orthopaedic Clinics Market By Region, From 2018–2023( USD Billion )
  19. Asia Pacific Ambulatory Care Centres Market By Region, From 2018–2023( USD Billion )
  20. Asia Pacific Research and Academic Institutes Market By Region, From 2018–2023( USD Billion )
  21. Asia Pacific Dental Clinics & Facilities Market By Region, From 2018–2023( USD Billion )
  22. Japan Orthobiologics  Market By Product , From 2018–2023( USD Billion )
  23. Japan Orthobiologics  Market By Application , From 2018–2023( USD Billion )
  24. Japan Orthobiologics  Market By End Users , From 2018–2023( USD Billion )
  25. China Orthobiologics  Market By Product , From 2018–2023( USD Billion )
  26. China Orthobiologics  Market By Application , From 2018–2023( USD Billion )
  27. China Orthobiologics  Market By End Users , From 2018–2023( USD Billion )
  28. India Orthobiologics  Market By Product , From 2018–2023( USD Billion )
  29. India Orthobiologics  Market By Application , From 2018–2023( USD Billion )
  30. India Orthobiologics  Market By End Users , From 2018–2023( USD Billion )
  31. Australia Orthobiologics  Market By Product , From 2018–2023( USD Billion )
  32. Australia Orthobiologics  Market By Application , From 2018–2023( USD Billion )
  33. Australia Orthobiologics  Market By End Users , From 2018–2023( USD Billion )
  34. South Korea Orthobiologics  Market By Product , From 2018–2023( USD Billion )
  35. South Korea Orthobiologics  Market By Application , From 2018–2023( USD Billion )
  36. South Korea Orthobiologics  Market By End Users , From 2018–2023( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Request Sample